DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

Founded in 2009, Olive Medical is a worldwide medical device manufacturing company that provides affordable HD MIS imaging equipment to the operating room and physician offices. Olive Medical has 20 employees and its visualization technology has been sold in 20 countries throughout the world.

The Olive Medical visualization portfolio augments the DePuy Synthes Mitek Sports Medicine arthroscopy line and will enable DePuy Synthes Companies to enter the arthroscopic visualization market to serve patients with shoulder, knee, hip, and small joint pain or injury.

Olive Medical's visualization systems complement the Mitek Sports Medicine procedural enablement portfolio, which includes the VAPR^® Radiofrequency Systems with electrodes used for tissue ablation and coagulation, and the FMS fluid management and tissue debridement system, which maximizes and maintains optimal visualization along with integrated soft tissue and bone shaving functionality. Both the VAPR and FMS systems are used alongside visualization in the operating room. Mitek Sports Medicine also provides implants and instruments for minimally invasive soft tissue repair, including a full line of screws and suture anchors addressing a full range of arthroscopic sports medicine procedures.

Olive Medical currently provides a cost effective, high definition visualization solution for customers. The newly combined portfolio and capabilities of the two companies will enable DePuy Synthes Companies to continue development of cost-effective, advanced visualization solutions to meet the evolving needs of customers and patients.

With the acquisition of Olive Medical, DePuy Synthes Companies will provide arthroscopic visualization solutions as part of its full-line offering and expand access to the technology through the company's extensive global distribution network. The acquisition also strengthens DePuy Synthes Companies' offering as a single source provider of orthopaedic products, programs and services for customers who are seeking to simplify supplier networks.

Mitek Sports Medicine has a long history as a global leader in sports medicine. In addition to arthroscopy solutions, Mitek Sports Medicine is committed to offering solutions for early intervention, including ORTHOVISC^® High Molecular Weight Hyaluronan, and more recently MONOVISC^® High Molecular Weight Hyaluronan, injectable treatments for pain associated with osteoarthritis of the knee.